ArticleClinical and translational allergy2024
CRUSE
Open access · goldAbstract read
In one paragraph
Article in Clinical and translational allergy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
14.6field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.
- The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria.Allergy · 2026Guideline
- ARIA-EAACI 2025: Person-Centred, Digitally Enabled and Artificial Intelligence-Assisted Change Management in Airway Diseases: An OECD Best Practice for Integrated Care for Chronic Diseases.Clinical and translational allergy · 2026Article
- Why physicians underuse patient-reported outcomes in atopic dermatitis and chronic urticaria - Insights from the UCARE/ADCARE PROMUSE study.The World Allergy Organization journal · 2026Article
- Knowledge among primary care physicians on urticaria treatment: Impact of educational interventions.The journal of allergy and clinical immunology. Global · 2026Article
- Clinical phenotypes and molecular endotypes of chronic urticaria: Linking clinical expression to underlying immune mechanisms.Asia Pacific allergy · 2026Review
- A Concordance Study between Patient Acceptable Symptom State (PASS) and Disease Activity in Chronic Spontaneous Urticaria.Dermatology practical & conceptual · 2026Article
- Integrating Technology into Urticaria Management: Telemedicine, Remote Monitoring and Patient-Centered Care.Biomedicines · 2026Review
- Simulating the impact of an educational and digital approach using patient journey modelling to overcome practical challenges in the management of chronic spontaneous urticaria in Germany.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2026Article
- Advancements and challenges in the management of chronic inducible urticaria.Frontiers in immunology · 2026Review
- Treatment Approaches for Omalizumab-Refractory Chronic Spontaneous Urticaria.Journal of inflammation research · 2026Review
- Teledermatology to Support Self-Care in Chronic Spontaneous Urticaria.JMIR dermatology · 2025Article
- Key Predictors of Adherence to a Mobile Health App for Managing Chronic Spontaneous Urticaria.Clinical and translational allergy · 2025Article
- Beyond Antihistamines: How Biologic and Small-Molecule Therapies Are Transforming Chronic Spontaneous Urticaria Care in Adults.Clinical drug investigation · 2025Review
- An Overview of Chronic Spontaneous Urticaria: Diagnosis, Management, and Treatment.Allergy, asthma & immunology research · 2025Review
- Unmet needs in hereditary angioedema: an international survey of physicians.Orphanet journal of rare diseases · 2025Article
- Acceptance and perceived usefulness of digital health services in the management of chronic urticaria: a survey of patients and physicians.BMC health services research · 2025Article
- Global productivity, international collaborations, and research trends in chronic spontaneous urticaria: A bibliometric overview.The journal of allergy and clinical immunology. Global · 2025Article
- Adaptation and Linguistic Validation of Angioedema PROMs in Latvian for Assessing Recurrent Angioedema.Journal of clinical medicine · 2025Article
- Disease control and quality of life in chronic spontaneous urticaria and recurrent angioedema are strongly linked, but not in all patients.Clinical and translational allergy · 2025Article
- CRUSEClinical and translational allergy · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
42 authors at 20 institutions in 25 countries.
Sophia NeisingerUrticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID https://orcid.org/0009-0000-5967-4809
Bernardo Sousa PintoFaculty of Medicine, MEDCIDS-Department of Community Medicine, Information and Health Decision Sciences, University of Porto, Porto, Portugal.ORCID https://orcid.org/0000-0002-1277-3401
Aiste RamanauskaiteUrticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID https://orcid.org/0009-0004-9289-5960
Jean BousquetUrticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0002-4061-4766
Karsten WellerUrticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0003-4437-0313
Martin MetzUrticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0002-4070-9976
Markus MagerlUrticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0001-9218-5468
Emek KocatürkUrticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0003-2801-0959
Ivan Cherrez-OjedaUniversidad Espíritu Santo, Respiralab Research Center, Guayaquil, Ecuador.ORCID https://orcid.org/0000-0002-1610-239X
Ana M Gimenez-ArnauDepartment of Dermatology, UCARE, Hospital del Mar and Research Institute, Universitat Pompeu Fabra, Barcelona, Spain.ORCID https://orcid.org/0000-0001-5434-7753
Claudio Alberto S ParisiAdult and Pediatric Allergy Sections of the Italian Hospital of Buenos Aires, Buenos Aires, Argentina.
Sabine AltrichterUrticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0001-9955-385X
Luis Felipe EnsinaDivision of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, Federal University of Sao Paulo, Sao Paulo, Brazil.
Laurence BouilletNational Reference Center for Angioedema, Internal Medicine Department, Grenoble University Hospital, Grenoble, France.
Riccardo AseroAmbulatorio di Allergologia, Clinica San Carlo, Paderno Dugnano (MI), Italy.
Margarida GonçaloFaculty of Medicine, Coimbra University Hospital, University of Coimbra, Coimbra, Portugal.ORCID https://orcid.org/0000-0001-6842-1360
Carole GuilletDepartment of Dermatology, University Hospital Zurich, Zurich, Switzerland.
Krzysztof RutkowskiUrticaria Clinic, St John's Institute of Dermatology, Guy's and St Thomas' Hospital, London, UK.
Jonathan A BernsteinDivision of Rheumatology, Allergy and Immunology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Hannah HardinOhio University Heritage College of Osteopathic Medicine, Cleveland, Ohio, USA.
Kiran GodseDepartment of Dermatology, Dr D Y Patil Medical College and Hospital, Navi Mumbai, India.
Zenon BrzozaDivision of Allergology, Department of Internal Diseases, Institute of Medical Sciences, University of Opole, Opole, Poland.
Jose Ignacio Larco SousaDepartment of Allergy, UCARE, Clinica San Felipe, Lima, Peru.
Simon Francis ThomsenDepartment of Biomedical Sciences, Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-4838-300X
Martijn van DoornDepartment of Dermatology, UCARE, Erasmus MC, Rotterdam, The Netherlands.
Michihiro HideDepartment of Dermatology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
Young-Min YeDepartment of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea.
Staffan VanderseeDermatologie/Venerologie, Bundeswehrkrankenhaus Berlin, Akademisches Lehrkrankenhaus der Charité, Berlin, Germany.
Lāsma LapiņaAllergic Diseases Diagnosis and Treatment Center, Riga Stradins University, Pauls Stradins Clinical University Hospital, Riga, Latvia.
Jonny PeterACARE Centre, Division of Allergy and Clinical Immunology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.ORCID https://orcid.org/0000-0002-2658-0723
Zuotao ZhaoDepartment of Dermatology and Venerology, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, National Clinical Research Center for Skin and Immune Diseases, Peking University First Hospital, Beijing, China.ORCID https://orcid.org/0000-0002-9595-6050
Lianyi HanGreater Bay Area Institute of Precision Medicine (Guangzhou), School of Life Sciences, Fudan University, Shanghai, China.
Iman NasrDepartment of Clinical Immunology and Allergy, Royal Hospital, Muscat, Oman.
Heike Rockmann-HelmbachDepartment of Dermatology/Allergology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
Jennifer Astrup SørensenDepartment of Biomedical Sciences, Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
Rabia Öztaş KaraDepartment of Dermatology, Sakarya University Faculty of Medicine, Sakarya, Turkey.
Natalja KurjāneAllergic Diseases Diagnosis and Treatment Center, Riga Stradins University, Pauls Stradins Clinical University Hospital, Riga, Latvia.
Andrii I KurchenkoDepartment of Clinical and Laboratory Immunology, Allergology and Medical Genetics, Bogomolets National Medical University, Kyiv, Ukraine.
Igor KaidashevPoltava State Medical University, Poltava, Ukraine.
Vladyslav TsarykDepartment of Clinical and Laboratory Immunology, Allergology and Medical Genetics, Bogomolets National Medical University, Kyiv, Ukraine.
Roman StepanenkoDepartment of Dermatology and Venereology with Cosmetology Course, Bogomolets National Medical University, Kyiv, Ukraine.
Marcus MaurerUrticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0002-4121-481X
Humboldt-Universität zu Berlin · DEBogomolets National Medical University · UAPauls Stradiņš Clinical University Hospital · LVUniversidade do Porto · PTUniversity of Copenhagen · DKAjou University · KRBundeswehrkrankenhaus · DECentre Hospitalier Universitaire de Grenoble · FRCentro Peruano de Estudios Sociales · PEDr. D. Y. Patil Medical College, Hospital and Research Centre · INErasmus MC · NLFudan University · CNHiroshima City Asa Citizens Hospital · JPHospital Italiano de Buenos Aires · ARJohannes Kepler University of Linz · ATKoç University · TROhio University · USOspedale San Carlo · ITPeking University · CNPoltava V.G. Korolenko National Pedagogical University · UA
Funding
Celldex TherapeuticsMoxieNovartisUCARE (Urticaria Centers of Reference and Excellence)
Abstract
backgroundChronic spontaneous urticaria (CSU) is unpredictable and can severely impair patients' quality of life. Patients with CSU need a convenient, user-friendly platform to complete patient-reported outcome measures (PROMs) on their mobile devices. CRUSE
methodsCRUSE
resultsCRUSE
conclusionsThe initial data from CRUSE
Indexed as
chronic urticaria self evaluation (CRUSE®) appdigital toolsmHealth appspatient-reported outcome measureswheals and angioedema
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.